The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nebulizer Inhalers Market Research Report 2025
Synopsis
Nebulizer inhaler is a kind of equipment used to treat upper respiratory tract diseases, which belongs to medical device. It is mainly used to treat various diseases of the upper and lower respiratory system. It is an important and effective treatment method in the treatment of respiratory system diseases. The drug liquid is atomized into tiny particles by an atomizing inhaler, and the drug enters the respiratory tract and lungs through inhalation. Partial deposition, so as to achieve the purpose of painless, rapid and effective treatment.
Global Nebulizer Inhalers market is projected to reach US$ 1164.3 million in 2029, increasing from US$ 871.3 million in 2022, with the CAGR of 4.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nebulizer Inhalers market research.
A nebulizer is a drug delivery device that delivers medicine to the lungs in the form of a mist. These devices pump pressurized air through a liquid to create a fine mist that is inhaled through a mouthpiece or face mask. These machines are designed to treat asthma, cystic fibrosis, chronic obstructive pulmonary disease and other respiratory diseases. Asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases place a huge economic burden on healthcare systems around the world. For example, according to statistics released by the Asthma and Allergy Foundation of America in April 2022, about 25 million people in the United States suffer from asthma. Likewise, according to a July 2021 article by the Greater London Authority, around 337,500 people in London suffer from asthma attacks due to poor air quality. The prevalence of these diseases has increased due to a combination of factors including increasing smoking population and poor air quality. According to the Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease report, the European Union spends around 6% of its total healthcare budget each year on managing respiratory diseases (direct costs). Furthermore, COPD accounts for around 60% of the EU's total annual expenditure on respiratory diseases, the report said. In emerging countries, the prevalence rate is gradually increasing, resulting in a large number of patients suffering from respiratory diseases. Various initiatives taken by the government to promote early diagnosis and treatment have resulted in an increasing number of patients receiving treatment. Additionally, the constant introduction of new products in the market, including vaping devices, is crucial to driving the adoption of these devices. The market is expected to witness substantial growth over the forecast period owing to rising incidence of respiratory diseases globally and increasing geriatric population. Growing demand for innovative respiratory drug delivery devices and rapid adoption of these devices among the patient population is likely to drive their usage over the forecast period.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nebulizer Inhalers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Agilent Technologies
PHILIPS
Pulox
Omron
Allied Healthcare Products
PARI
Yuwell
Emser
Drive DeVilbiss Healthcare
Rossmax International
BD
Leyi
GF Health Products
Briggs Healthcare
Trudell Medical International
Heal Force Bio-Meditech Holdings
Roche
3M
Bayer
Johnson & Johnson
Segment by Type
Pneumatic Nebulizer Machine
Ultrasonic Nebulizer Machine
Mesh Nebulizer Machine
Segment by Application
Hospital
Clinic
Home Care
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Nebulizer Inhalers report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Nebulizer inhaler is a kind of equipment used to treat upper respiratory tract diseases, which belongs to medical device. It is mainly used to treat various diseases of the upper and lower respiratory system. It is an important and effective treatment method in the treatment of respiratory system diseases. The drug liquid is atomized into tiny particles by an atomizing inhaler, and the drug enters the respiratory tract and lungs through inhalation. Partial deposition, so as to achieve the purpose of painless, rapid and effective treatment.
Global Nebulizer Inhalers market is projected to reach US$ 1164.3 million in 2029, increasing from US$ 871.3 million in 2022, with the CAGR of 4.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nebulizer Inhalers market research.
A nebulizer is a drug delivery device that delivers medicine to the lungs in the form of a mist. These devices pump pressurized air through a liquid to create a fine mist that is inhaled through a mouthpiece or face mask. These machines are designed to treat asthma, cystic fibrosis, chronic obstructive pulmonary disease and other respiratory diseases. Asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases place a huge economic burden on healthcare systems around the world. For example, according to statistics released by the Asthma and Allergy Foundation of America in April 2022, about 25 million people in the United States suffer from asthma. Likewise, according to a July 2021 article by the Greater London Authority, around 337,500 people in London suffer from asthma attacks due to poor air quality. The prevalence of these diseases has increased due to a combination of factors including increasing smoking population and poor air quality. According to the Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease report, the European Union spends around 6% of its total healthcare budget each year on managing respiratory diseases (direct costs). Furthermore, COPD accounts for around 60% of the EU's total annual expenditure on respiratory diseases, the report said. In emerging countries, the prevalence rate is gradually increasing, resulting in a large number of patients suffering from respiratory diseases. Various initiatives taken by the government to promote early diagnosis and treatment have resulted in an increasing number of patients receiving treatment. Additionally, the constant introduction of new products in the market, including vaping devices, is crucial to driving the adoption of these devices. The market is expected to witness substantial growth over the forecast period owing to rising incidence of respiratory diseases globally and increasing geriatric population. Growing demand for innovative respiratory drug delivery devices and rapid adoption of these devices among the patient population is likely to drive their usage over the forecast period.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nebulizer Inhalers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Agilent Technologies
PHILIPS
Pulox
Omron
Allied Healthcare Products
PARI
Yuwell
Emser
Drive DeVilbiss Healthcare
Rossmax International
BD
Leyi
GF Health Products
Briggs Healthcare
Trudell Medical International
Heal Force Bio-Meditech Holdings
Roche
3M
Bayer
Johnson & Johnson
Segment by Type
Pneumatic Nebulizer Machine
Ultrasonic Nebulizer Machine
Mesh Nebulizer Machine
Segment by Application
Hospital
Clinic
Home Care
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Nebulizer Inhalers report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Nebulizer Inhalers Market Overview
1.1 Product Overview and Scope of Nebulizer Inhalers
1.2 Nebulizer Inhalers Segment by Type
1.2.1 Global Nebulizer Inhalers Market Value Comparison by Type (2023-2029)
1.2.2 Pneumatic Nebulizer Machine
1.2.3 Ultrasonic Nebulizer Machine
1.2.4 Mesh Nebulizer Machine
1.3 Nebulizer Inhalers Segment by Application
1.3.1 Global Nebulizer Inhalers Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.3.5 Others
1.4 Global Nebulizer Inhalers Market Size Estimates and Forecasts
1.4.1 Global Nebulizer Inhalers Revenue 2018-2029
1.4.2 Global Nebulizer Inhalers Sales 2018-2029
1.4.3 Global Nebulizer Inhalers Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Nebulizer Inhalers Market Competition by Manufacturers
2.1 Global Nebulizer Inhalers Sales Market Share by Manufacturers (2018-2023)
2.2 Global Nebulizer Inhalers Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Nebulizer Inhalers Average Price by Manufacturers (2018-2023)
2.4 Global Nebulizer Inhalers Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Nebulizer Inhalers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nebulizer Inhalers, Product Type & Application
2.7 Nebulizer Inhalers Market Competitive Situation and Trends
2.7.1 Nebulizer Inhalers Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nebulizer Inhalers Players Market Share by Revenue
2.7.3 Global Nebulizer Inhalers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nebulizer Inhalers Retrospective Market Scenario by Region
3.1 Global Nebulizer Inhalers Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Nebulizer Inhalers Global Nebulizer Inhalers Sales by Region: 2018-2029
3.2.1 Global Nebulizer Inhalers Sales by Region: 2018-2023
3.2.2 Global Nebulizer Inhalers Sales by Region: 2024-2029
3.3 Global Nebulizer Inhalers Global Nebulizer Inhalers Revenue by Region: 2018-2029
3.3.1 Global Nebulizer Inhalers Revenue by Region: 2018-2023
3.3.2 Global Nebulizer Inhalers Revenue by Region: 2024-2029
3.4 North America Nebulizer Inhalers Market Facts & Figures by Country
3.4.1 North America Nebulizer Inhalers Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Nebulizer Inhalers Sales by Country (2018-2029)
3.4.3 North America Nebulizer Inhalers Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nebulizer Inhalers Market Facts & Figures by Country
3.5.1 Europe Nebulizer Inhalers Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Nebulizer Inhalers Sales by Country (2018-2029)
3.5.3 Europe Nebulizer Inhalers Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nebulizer Inhalers Market Facts & Figures by Country
3.6.1 Asia Pacific Nebulizer Inhalers Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Nebulizer Inhalers Sales by Country (2018-2029)
3.6.3 Asia Pacific Nebulizer Inhalers Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nebulizer Inhalers Market Facts & Figures by Country
3.7.1 Latin America Nebulizer Inhalers Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Nebulizer Inhalers Sales by Country (2018-2029)
3.7.3 Latin America Nebulizer Inhalers Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nebulizer Inhalers Market Facts & Figures by Country
3.8.1 Middle East and Africa Nebulizer Inhalers Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Nebulizer Inhalers Sales by Country (2018-2029)
3.8.3 Middle East and Africa Nebulizer Inhalers Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Nebulizer Inhalers Sales by Type (2018-2029)
4.1.1 Global Nebulizer Inhalers Sales by Type (2018-2023)
4.1.2 Global Nebulizer Inhalers Sales by Type (2024-2029)
4.1.3 Global Nebulizer Inhalers Sales Market Share by Type (2018-2029)
4.2 Global Nebulizer Inhalers Revenue by Type (2018-2029)
4.2.1 Global Nebulizer Inhalers Revenue by Type (2018-2023)
4.2.2 Global Nebulizer Inhalers Revenue by Type (2024-2029)
4.2.3 Global Nebulizer Inhalers Revenue Market Share by Type (2018-2029)
4.3 Global Nebulizer Inhalers Price by Type (2018-2029)
5 Segment by Application
5.1 Global Nebulizer Inhalers Sales by Application (2018-2029)
5.1.1 Global Nebulizer Inhalers Sales by Application (2018-2023)
5.1.2 Global Nebulizer Inhalers Sales by Application (2024-2029)
5.1.3 Global Nebulizer Inhalers Sales Market Share by Application (2018-2029)
5.2 Global Nebulizer Inhalers Revenue by Application (2018-2029)
5.2.1 Global Nebulizer Inhalers Revenue by Application (2018-2023)
5.2.2 Global Nebulizer Inhalers Revenue by Application (2024-2029)
5.2.3 Global Nebulizer Inhalers Revenue Market Share by Application (2018-2029)
5.3 Global Nebulizer Inhalers Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Agilent Technologies
6.1.1 Agilent Technologies Corporation Information
6.1.2 Agilent Technologies Description and Business Overview
6.1.3 Agilent Technologies Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Agilent Technologies Nebulizer Inhalers Product Portfolio
6.1.5 Agilent Technologies Recent Developments/Updates
6.2 PHILIPS
6.2.1 PHILIPS Corporation Information
6.2.2 PHILIPS Description and Business Overview
6.2.3 PHILIPS Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.2.4 PHILIPS Nebulizer Inhalers Product Portfolio
6.2.5 PHILIPS Recent Developments/Updates
6.3 Pulox
6.3.1 Pulox Corporation Information
6.3.2 Pulox Description and Business Overview
6.3.3 Pulox Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pulox Nebulizer Inhalers Product Portfolio
6.3.5 Pulox Recent Developments/Updates
6.4 Omron
6.4.1 Omron Corporation Information
6.4.2 Omron Description and Business Overview
6.4.3 Omron Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Omron Nebulizer Inhalers Product Portfolio
6.4.5 Omron Recent Developments/Updates
6.5 Allied Healthcare Products
6.5.1 Allied Healthcare Products Corporation Information
6.5.2 Allied Healthcare Products Description and Business Overview
6.5.3 Allied Healthcare Products Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Allied Healthcare Products Nebulizer Inhalers Product Portfolio
6.5.5 Allied Healthcare Products Recent Developments/Updates
6.6 PARI
6.6.1 PARI Corporation Information
6.6.2 PARI Description and Business Overview
6.6.3 PARI Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.6.4 PARI Nebulizer Inhalers Product Portfolio
6.6.5 PARI Recent Developments/Updates
6.7 Yuwell
6.6.1 Yuwell Corporation Information
6.6.2 Yuwell Description and Business Overview
6.6.3 Yuwell Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Yuwell Nebulizer Inhalers Product Portfolio
6.7.5 Yuwell Recent Developments/Updates
6.8 Emser
6.8.1 Emser Corporation Information
6.8.2 Emser Description and Business Overview
6.8.3 Emser Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Emser Nebulizer Inhalers Product Portfolio
6.8.5 Emser Recent Developments/Updates
6.9 Drive DeVilbiss Healthcare
6.9.1 Drive DeVilbiss Healthcare Corporation Information
6.9.2 Drive DeVilbiss Healthcare Description and Business Overview
6.9.3 Drive DeVilbiss Healthcare Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Drive DeVilbiss Healthcare Nebulizer Inhalers Product Portfolio
6.9.5 Drive DeVilbiss Healthcare Recent Developments/Updates
6.10 Rossmax International
6.10.1 Rossmax International Corporation Information
6.10.2 Rossmax International Description and Business Overview
6.10.3 Rossmax International Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Rossmax International Nebulizer Inhalers Product Portfolio
6.10.5 Rossmax International Recent Developments/Updates
6.11 BD
6.11.1 BD Corporation Information
6.11.2 BD Nebulizer Inhalers Description and Business Overview
6.11.3 BD Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.11.4 BD Nebulizer Inhalers Product Portfolio
6.11.5 BD Recent Developments/Updates
6.12 Leyi
6.12.1 Leyi Corporation Information
6.12.2 Leyi Nebulizer Inhalers Description and Business Overview
6.12.3 Leyi Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Leyi Nebulizer Inhalers Product Portfolio
6.12.5 Leyi Recent Developments/Updates
6.13 GF Health Products
6.13.1 GF Health Products Corporation Information
6.13.2 GF Health Products Nebulizer Inhalers Description and Business Overview
6.13.3 GF Health Products Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.13.4 GF Health Products Nebulizer Inhalers Product Portfolio
6.13.5 GF Health Products Recent Developments/Updates
6.14 Briggs Healthcare
6.14.1 Briggs Healthcare Corporation Information
6.14.2 Briggs Healthcare Nebulizer Inhalers Description and Business Overview
6.14.3 Briggs Healthcare Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Briggs Healthcare Nebulizer Inhalers Product Portfolio
6.14.5 Briggs Healthcare Recent Developments/Updates
6.15 Trudell Medical International
6.15.1 Trudell Medical International Corporation Information
6.15.2 Trudell Medical International Nebulizer Inhalers Description and Business Overview
6.15.3 Trudell Medical International Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Trudell Medical International Nebulizer Inhalers Product Portfolio
6.15.5 Trudell Medical International Recent Developments/Updates
6.16 Heal Force Bio-Meditech Holdings
6.16.1 Heal Force Bio-Meditech Holdings Corporation Information
6.16.2 Heal Force Bio-Meditech Holdings Nebulizer Inhalers Description and Business Overview
6.16.3 Heal Force Bio-Meditech Holdings Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Heal Force Bio-Meditech Holdings Nebulizer Inhalers Product Portfolio
6.16.5 Heal Force Bio-Meditech Holdings Recent Developments/Updates
6.17 Roche
6.17.1 Roche Corporation Information
6.17.2 Roche Nebulizer Inhalers Description and Business Overview
6.17.3 Roche Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Roche Nebulizer Inhalers Product Portfolio
6.17.5 Roche Recent Developments/Updates
6.18 3M
6.18.1 3M Corporation Information
6.18.2 3M Nebulizer Inhalers Description and Business Overview
6.18.3 3M Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.18.4 3M Nebulizer Inhalers Product Portfolio
6.18.5 3M Recent Developments/Updates
6.19 Bayer
6.19.1 Bayer Corporation Information
6.19.2 Bayer Nebulizer Inhalers Description and Business Overview
6.19.3 Bayer Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Bayer Nebulizer Inhalers Product Portfolio
6.19.5 Bayer Recent Developments/Updates
6.20 Johnson & Johnson
6.20.1 Johnson & Johnson Corporation Information
6.20.2 Johnson & Johnson Nebulizer Inhalers Description and Business Overview
6.20.3 Johnson & Johnson Nebulizer Inhalers Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Johnson & Johnson Nebulizer Inhalers Product Portfolio
6.20.5 Johnson & Johnson Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nebulizer Inhalers Industry Chain Analysis
7.2 Nebulizer Inhalers Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nebulizer Inhalers Production Mode & Process
7.4 Nebulizer Inhalers Sales and Marketing
7.4.1 Nebulizer Inhalers Sales Channels
7.4.2 Nebulizer Inhalers Distributors
7.5 Nebulizer Inhalers Customers
8 Nebulizer Inhalers Market Dynamics
8.1 Nebulizer Inhalers Industry Trends
8.2 Nebulizer Inhalers Market Drivers
8.3 Nebulizer Inhalers Market Challenges
8.4 Nebulizer Inhalers Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
